1. Home
  2. DCTH vs MATW Comparison

DCTH vs MATW Comparison

Compare DCTH & MATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • MATW
  • Stock Information
  • Founded
  • DCTH 1988
  • MATW 1850
  • Country
  • DCTH United States
  • MATW United States
  • Employees
  • DCTH N/A
  • MATW N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • MATW Metal Fabrications
  • Sector
  • DCTH Health Care
  • MATW Telecommunications
  • Exchange
  • DCTH Nasdaq
  • MATW Nasdaq
  • Market Cap
  • DCTH 518.0M
  • MATW 603.7M
  • IPO Year
  • DCTH N/A
  • MATW 1994
  • Fundamental
  • Price
  • DCTH $11.87
  • MATW $19.48
  • Analyst Decision
  • DCTH Strong Buy
  • MATW Strong Buy
  • Analyst Count
  • DCTH 4
  • MATW 1
  • Target Price
  • DCTH $22.75
  • MATW $40.00
  • AVG Volume (30 Days)
  • DCTH 458.0K
  • MATW 238.0K
  • Earning Date
  • DCTH 05-13-2025
  • MATW 04-30-2025
  • Dividend Yield
  • DCTH N/A
  • MATW 5.14%
  • EPS Growth
  • DCTH N/A
  • MATW N/A
  • EPS
  • DCTH N/A
  • MATW N/A
  • Revenue
  • DCTH $37,205,000.00
  • MATW $1,747,593,000.00
  • Revenue This Year
  • DCTH $128.78
  • MATW N/A
  • Revenue Next Year
  • DCTH $54.07
  • MATW $1.87
  • P/E Ratio
  • DCTH N/A
  • MATW N/A
  • Revenue Growth
  • DCTH 1701.69
  • MATW N/A
  • 52 Week Low
  • DCTH $5.04
  • MATW $18.50
  • 52 Week High
  • DCTH $16.97
  • MATW $32.24
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 47.65
  • MATW 35.05
  • Support Level
  • DCTH $11.05
  • MATW $18.85
  • Resistance Level
  • DCTH $11.84
  • MATW $20.25
  • Average True Range (ATR)
  • DCTH 0.97
  • MATW 1.29
  • MACD
  • DCTH 0.09
  • MATW -0.02
  • Stochastic Oscillator
  • DCTH 57.89
  • MATW 24.50

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About MATW Matthews International Corporation

Matthews International Corp is a personal services company that primarily provides brand solution services, memorialization products, and industrial products in the United States and Europe. The majority of Matthews' revenue is derived from its SGK Brand Solutions business, which provides brand development services, printing equipment, creative design services, and embossing tools to the consumer packaged goods and packaging industries. The company's Memorialization segment, which sells bronze and granite memorials, caskets, and cremation equipment to the cemetery and funeral home industries, also contributes a significant amount. Most of Matthews' revenue is generated from sales made in the U.S., while European customers also contribute a sizable percentage.

Share on Social Networks: